Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Intimation Of The 172Nd Board Meeting

 Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015; we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 30, 2019 at 3:00 P.M. at the Registered Office of the Company to consider the matters as stated.
20-05-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Half Yearly Certificate Under Regulations 40(9) & 40(10) Of SEBI Listing Regulations, 2015

 In compliance to Regulation 40(9) & 40(10) of SEBI Listing Regulations, 2015; we furnish hereunder the certificate for the half year ended March 31, 2019 of Fredun Pharmaceuticals Limited as issued by Rajendra & Co., Practising Company Secretaries.
26-04-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Half Yearly Compliance Certificate Under Regulation 7(3) Of SEBI Listing Regulations, 2015

 In compliance to Regulation 7(3) of SEBI Listing Regulations, 2015; we furnish hereunder the Certificate, duly signed by the Director of Fredun Pharmaceuticals Limited and by Authorized Representative of 'Purva Sharegistry (India) Pvt. Ltd.', designated Share Transfer Agent of the Company for the half year ended March 31, 2019.
19-04-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended March 31, 2019

 Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
10-04-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in Directorate

 In compliance to Regulation 30 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Tuesday, April 9, 2019; had considered and approved the Appointment of Mr. Fredun Medhora as the Chief Financial Officer (hereinafter referred to as 'the CFO') of the Company with immediate effect.
09-04-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended March 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priyanka ChaturvediDesignation :- Company Secretary and Compliance Officer
08-04-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

 Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and "Code of Conduct for Prevention of Insider Trading" of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), the trading window for dealing in the securities of the Company will remain closed for designated persons and their immediate relatives with immediate effect till 48 hours after the end of the Board Meeting wherein, interalia; the approval of Audited Financial Results for the year ended March 31, 2019; would be considered and approved.
04-04-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to Regulation 30 of SEBI Listing Regulations, 2015; the Board hereby informs that today i.e. March 29, 2019 the Board through Circular Resolution had considered and approved the revised Policies and Code under SEBI (Prohibition of Insider Trading) Regulations (Amendment), 2019.
29-03-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 We enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for Quarter and Nine Months ended December 2018; as approved by the Board in its Meeting held on Monday, February 11, 2019; published in Business Standard & Mumbai Lakshadeep newspaper(s) on February 12, 2019.
12-02-2019
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Approved Unaudited Financial Results For Quarter Ended December 31, 2018

 In compliance to Regulation 33 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Monday, February 11, 2019; had considered and approved the Unaudited Financial Results of the Company for the Quarter ended December 31, 2018; along with the Limited Review Report issued by M/s. Savla & Associates, Statutory Auditors of the Company; the copies of which are attached hereunder.
11-02-2019
Next Page
Close

Let's Open Free Demat Account